Could Valeant Pharmaceuticals Be Overcooked Down Here?

March 17, 2016   |   March 2016 Bond Updates
Even if earnings were cut by half from already lowered guidance , could VRX be cheap?

View more at: http://www.forbes.com/sites/jaysomaney/2016/03/16/could-valeant-pharmaceuticals-be-overcooked-down-here/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/